Digital and Artificial intelligence are reshaping the patient care journey across healthcare systems. Yet for many patients, that journey still feels fragmented—diagnostic pathways are long, administrative steps can be discouraging, and support remains inconsistent.
At Sanofi, we believe no one should be left undiagnosed or left untreated to the best available standards of care. That’s why we use Digital and AI to help turn scientific innovation into real impact—supporting patients at every stage of their journey, from first symptoms to long-term care.
AI Across the Patient Care Journey
Sanofi’s approach spans two interconnected phases of care:
-
Pre-Prescription (Pre-RX): identifying, diagnosing, and guiding patients earlier
-
Post-Prescription (Post-RX): onboarding, supporting, and retaining patients on therapy
AI, data, and digital ecosystems connect these stages, reducing friction and enabling more consistent, personalized support.
Digital & AI allows us to simplify what sits behind the healthcare system. When we remove complexity from the process, we create more space for healthcare professionals, and support teams to focus on what truly matters—building a responsive healthcare ecosystem that helps patients chase their dreams.
Pius S Hornstein, PhD.
Global Head Digital Global Business Units.
Pre-prescription: Digital & AI for Diagnosis and Patient Identification Earlier
Critical gaps in diagnosis and treatment affect patients everywhere—from the years-long diagnostic odysseys in rare disease to the clinical inertia that leaves millions with chronic conditions undertreated. And in some areas, over 70% of patients never reach prescription. AI-driven tools are now identifying these gaps and accelerating patients toward the right care.
Accelrare: Digital Diagnosis for Rare Diseases
AccelRare, designed exclusively for healthcare professionals, delivers a digital pre-diagnostic orientation in just eight minutes. It covers 310 rare diseases, was co-developed with more than 50 healthcare professionals. In 2025, more than 3,000 diagnostic questionnaires were completed, with a satisfaction score of 4.36 out of 5.
AI Tools for Patient Identification: Fabryfind, Medis and Cablivi.AI
Sanofi complements this with additional AI-enabled identification tools:
-
FabryFind, supporting early identification of high-risk patients
-
MedIS, using GenAI insights to detect care gaps and strengthen medical engagement
-
Cablivi.AI, predicting potential patients before diagnosis with ~90% accuracy
Post-Prescription: Digital & Ai-Powered Patient Support and Continuity
Once therapy is prescribed, new challenges emerge — from administrative complexity to sustaining long-term engagement. Digital and AI solutions help ensure patients start treatment smoothly and remain supported over time.
iCare+: A Connected Patient Support Platform
At the center is iCare+, Sanofi’s patient support platform, which supports more than 20 therapies and connects with over 50 external partners to streamline documentation, reimbursement, and coordination with specialty pharmacies. iCareLite extends these capabilities to additional geographies, enabling responsible scale while adapting to local constraints.
Companion App: Personalized Support for Patients Throughout Treatment
Patient-facing tools like Companion App deepen long-term engagement through personalized onboarding, educational content, injection tracking, and direct access to support teams. Since its U.S. launch in 2024, Companion App has enrolled more than 50,000 patients, with a satisfaction score of 4.52 out of 5.
Next Best Intervention (NBI): Ai-Driven Support Prioritization
AI further strengthens support through Next Best Intervention (NBI) models which helps prioritize outreach and tailor interactions—allowing Care teams to focus on moments that matter most.
Behind the scenes, different AI tools also streamline administrative workflows—accelerating onboarding, flagging missing information early, and more - helping patients access therapy faster, with fewer obstacles.
We are co-building a new generation of patient support. And now that the foundation is in place, the focus is shifting toward scale and intelligence.
Fabrice Bocquillon
Head of Digital Patient Experience
Patient support is not only about education, access, and affordability - it's increasingly about customer experience and continuity. By combining our PSS strategy with Digital & AI solutions we create a robust partner ecosystem. Building this system ensures far less patients fall through the cracks, from prescription through to long-term treatment adherence.
John Daly
Head of US Patient Support Services
Digital & AI in Patient Care for Simplifying, Streamlining, and Connecting Healthcare Processes and Access
Across the patient journey — from early identification to long-term support — Sanofi’s digital and AI solutions work together to remove barriers, reduce delays, and strengthen continuity of care. These tools reinforce our commitment to delivering meaningful innovation beyond the medicine itself.
Digital and AI do not replace the human experience; they enable it.
“Digital & AI allows us to simplify what sits behind the healthcare system. When we remove complexity from the process, we create more space for healthcare professionals, and support teams to focus on what truly matters—building a responsive healthcare ecosystem that helps patients chase their dreams”, says Pius S Hornstein, PhD. Global Head Digital Global Business Units.
By building an end-to-end ecosystem rooted in intelligence and simplicity, Sanofi moves closer to a future where no one is left undiagnosed or untreated— ensuring the impact of science is felt not only in medicines, but at every step of the journey that surrounds them.
The transformation of the patient journey is not a one-time announcement; it is an ongoing shift in how we design healthcare. That's why we will continue sharing more strategic insights on how Digital & AI are being embedded at scale: exploring the tools; the operating model; and the AI capabilities that work together as a coherent system designed to reduce friction and accelerate impact.